1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Apexign Inc (APGN)

  7. Apexign Inc (APGN) Financials

APGN

Apexign Inc
0.481
-0.007 (-1.43%)
Upgrade to Real-Time

Apexigen Inc. (APGN) Fundamentals
Apexigen Inc is a clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. The company's pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in clinical development, and also includes several preclinical stage immune-oncology programs.
SHARE INFORMATION
Market CapUS$ 12,211,757
Shares Outstanding24,561,055
Float24,083,083
Percent Float98.05%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -242.17
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions32
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months465
Institutional Holdings Percent7.3%
Institutional Sold Previous 3 Months44,035
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent2.6
Insider Sold Previous 3 Months25,594
Insider Shares Owned634,971
TRADING INFO
52 Week HighUS$ 31.35
52 Week LowUS$ 0.47
52 Week High ChangeUS$ -95.06
21 Day Moving AverageUS$ 0.8617
21 Day Extended Moving AverageUS$ 0.854561
50 Day Moving AverageUS$ 1.3278
50 Day Extended Moving AverageUS$ 1.1639
200 Day Moving AverageUS$ 4.4866
200 Day Extended Moving AverageUS$ 3.7606
10 Day Average Volume114,416
20 Day Average Volume167,722
30 Day Average Volume462,815
50 Day Average Volume785,117
Alpha-0.013354
Beta4.2203
Standard Deviation0.473217
R20.245788
7 Day Price ChangeUS$ -0.2561
7 Day Percent Change-34.0%
21 Day Price ChangeUS$ -0.3628
21 Day Percent Change-42.19%
30 Day Price ChangeUS$ -0.9228
30 Day Percent Change-64.99%
Month to Date Price ChangeUS$ -0.4028
Month to Date Percent Change-44.76%
Quarter to Date Price ChangeUS$ -0.1848
Quarter to Date Percent Change-27.1%
180 Day Price ChangeUS$ -4.54
180 Day Percent Change-90.13%
200 Day Price ChangeUS$ -4.73
200 Day Percent Change-90.49%
Year to Date Price ChangeUS$ -0.1848
Year to Date Percent Change-27.1%

Apexigen Inc. (APGN) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.40
Total Debt To Equity0.00
Int Coverage-3.50
Current Ratio1.30
Leverage Ratio1.10
Quick Ratio1.00
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ -1,245,104
Price to Sales0.00
Price to Free Cash-0.50
PE High Last 5 Years0.00
Price To Book2.40
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-103.53
Return on Equity-226.01
Return on Capital-317.53

Apexigen Inc. (APGN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorMoss Adams LLP
CEOXiaodong Yang
Emplyoees20
Last AuditUE
CIK0001814140
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address75 Shoreway Road
Suite C
San Carlos, CA 94070
Websitehttps://www.apexigen.com
Facsimile+1 650 931-6235
Telephone+1 650 931-6236
Email-
Your Recent History
NASDAQ
APGN
Apexign
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 10:18:49